News

The 2023 Endpoints 11; Regeneron’s gene editing ambitions; GSK’s research revamp; Ripple effect of Dana-Farber, Brigham breakup; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

News

TWO MEMORIAL HERMANN HOSPITALS RECOGNIZED BY VIZIENT AS 2023 BIRNBAUM QUALITY LEADERSHIP TOP PERFORMER

HOUSTON, Sept. 22, 2023 /PRNewswire/ — Memorial Hermann-Texas Medical Center (TMC) and Memorial Hermann Pearland Hospital have earned national recognition as top performers in delivering high-quality care by Vizient, Inc. Both institutions received the 2023 […]

News

TEXAS CHILDREN’S ANNOUNCES NEW PRESIDENT

Texas Children’s appoints Dr. Debra Feigin Sukin as its new President. HOUSTON, Sept. 22, 2023 /PRNewswire/ — Texas Children’s is pleased to announce the appointment of Debra Feigin Sukin, Ph.D., as the new President of […]

No Picture
News

Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 25, 2023

THE WOODLANDS, Texas, Sept. 22, 2023 /PRNewswire/ — Graf Acquisition Corp. IV (NYSE: GFOR, GFOR.U, GFOR WS) (the “Company” or “Graf”), announced today that on September 20, 2023, it adjourned, without conducting any business, the […]

News

Top-trained Spine Surgeons Provide Free Patient Guide for Artificial Disc Replacement, Available at CentersForArtificialDisc.com

AUSTIN, Texas, Sept. 22, 2023 /PRNewswire/ — If you’ve been told you have a herniated disc, you probably have been told you need a spinal fusion, which was the standard treatment for herniated discs in […]